Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration

ClinicalTrials.gov ID: NCT02087085

Public ClinicalTrials.gov record NCT02087085. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 5:12 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will assess the safety and efficacy of the brimonidine intravitreal implant in participants with geographic atrophy due to age-related macular degeneration.

Study identification

NCT ID
NCT02087085
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Allergan
Industry
Enrollment
310 participants

Conditions and interventions

Eligibility (public fields only)

Age range
55 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 9, 2014 (Actual)
Primary completion
Mar 30, 2018 (Actual)
Completion
Mar 30, 2018 (Actual)
Last update posted
Apr 23, 2019

2014 – 2018

United States locations

U.S. sites
23
U.S. states
11
U.S. cities
22
Facility City State ZIP Site status
Retinal Consultants of Arizona, Ltd., Retinal Research Institute Phoenix Arizona 85014 —
Associated Retina Consultants Phoenix Arizona 85020 —
University of California, San Diego, Jacobs Retina Center, Shiley Eye Center La Jolla California 92037 —
Northern California Retina Vitreous Associates Mountain View California 94040 —
Retina Consultants of Southern Colorado, PC Colorado Springs Colorado 80909 —
"National Ophthalmic Research Institute Retina Consultants of Southwest Florida" Fort Myers Florida 33912 —
Retina Specialty Institute Pensacola Florida 32503 —
Retina Vitreous Associates of Florida St. Petersburg Florida 33711 —
Southern Vitreoretinal Associates, PL Tallahassee Florida 32308 —
Center for Retina and Macular Disease Winter Haven Florida 33880 —
Georgia Retina Decatur Georgia 30030 —
Raj K. Maturi, MD Indianapolis Indiana 46290 —
Retina Associates of Western New York Rochester New York 14620 —
Charlotte Eye Ear Nose & Throat Associates, PA Charlotte North Carolina 28210 —
Oregon Retina, LLP Eugene Oregon 97401 —
Casey Eye Institute, Oregon Health and Science University Portland Oregon 97239 —
Mid Atlantic Retina, Wills Eye Retina Surgeons Philadelphia Pennsylvania 19107 —
Retina Research Institute of Texas Abilene Texas 79606 —
Texas Retina Associates Arlington Texas 76012 —
"Austin Retina Associates " Austin Texas 78705 —
Retina Foundation of the Southwest Dallas Texas 75231 —
Valley Retina Institute McAllen Texas 78503 —
Strategic Clinical Research Group, LLC Willow Park Texas 76087 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02087085, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 23, 2019 · Synced Nov 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02087085 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →